DLA Piper advises ResMed in agreement to acquire MatrixCare for US$750 million
DLA Piper represented ResMed (NYSE: RMD), a world-leading connected health company, in a definitive agreement to acquire privately held MatrixCare, a leader in US long-term post-acute care software, serving more than 15,000 providers across skilled nursing, life plan communities, senior living and private duty, for US$750 million.
The transaction is expected to close by the end of the second quarter of ResMed's fiscal year 2019. MatrixCare will continue to operate as a standalone business within ResMed's software-as-a-service (SaaS) portfolio, with targeted commercial, technical and operating links to ResMed and Brightree.
The DLA Piper team was led by partner Martin Nichols (San Diego) and included partners Neil Balmert, Mark Lehberg (both of San Diego), Nate McKitterick, Cisco Palao-Ricketts (both of Silicon Valley), Anna Spencer (Atlanta) and Paolo Morante (New York); and associates Chris Stevenson (Seattle), Jennifer Cumming (San Diego) and Milton Gregory (Atlanta).